Treatment of Hemodialysis-Associated Adynamic Bone Disease with Teriparatide (PTH<sub>1–34</sub>): A Pilot Study

Abstract

Teriparatide therapy might improve low BMD in hemodialysis patients with ABD. Further clinical studies are needed to establish teriparatide as a therapeutic option for dialysis patients with ABD.